Pseudopapilledema Combined with Idiopathic Papilledema in a Child Receiving Growth Hormone Treatment
10.3341/jkos.2020.61.12.1548
- Author:
Hee Chul LEE
1
;
Chan Keum PARK
Author Information
1. Department of Ophthalmology, Maryknoll Medical Center, Busan, Korea
- Publication Type:Case Report
- From:Journal of the Korean Ophthalmological Society
2020;61(12):1548-1552
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Purpose:We report a case of pseudopapilledema combined with idiopathic papilledema in a pediatric patient receiving growth hormone treatment.Case summary: An 11-year-old girl without any underlying disease presented with bilateral transient visual obscurations, a dark-adaptation disorder, and helplessness that developed while she had been on growth hormone therapy for 3 months at a local clinic. Reduced visual acuity (from 20/20 to 20/25) was observed on physical examination and bilateral optic disc edema on fundus examination, growth hormone was immediately discontinued. Four weeks later, fundus examination revealed papilledema of both eyes with mild red-green dyschromatopsia. Recombinant growth hormone-associated idiopathic papilledema combined with pseudopapilledema was suspected. Although growth hormone, had been discontinued, we scheduled further observation of the papilledema.
Conclusions:Papilledema was observed on fundus examination during growth hormone treatment and four weeks after discontinuation thereof. The symptoms improved, but mild papilledema combined with pseudopapilledema remained.
